Cargando…
Patient Reported Experiences and Delays During the Diagnostic Pathway for Pulmonary Fibrosis: A Multinational European Survey
Introduction: Pulmonary fibrosis includes a spectrum of diseases and is incurable. There is a variation in disease course, but it is often progressive leading to increased breathlessness, impaired quality of life, and decreased life expectancy. Detection of pulmonary fibrosis is challenging, which c...
Autores principales: | van der Sar, Iris G., Jones, Steve, Clarke, Deborah L., Bonella, Francesco, Fourrier, Jean Michel, Lewandowska, Katarzyna, Bermudo, Guadalupe, Simidchiev, Alexander, Strambu, Irina R., Wijsenbeek, Marlies S., Parfrey, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371687/ https://www.ncbi.nlm.nih.gov/pubmed/34422866 http://dx.doi.org/10.3389/fmed.2021.711194 |
Ejemplares similares
-
Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
por: Kreuter, Michael, et al.
Publicado: (2015) -
Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022) -
Exhaled breath analysis in interstitial lung disease
por: van der Sar, Iris G., et al.
Publicado: (2023) -
Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial
por: Molina-Molina, Maria, et al.
Publicado: (2023) -
Regulatory delays in a multinational clinical stroke trial
por: de Jonge, Jeroen C, et al.
Publicado: (2021)